Nippon Life Insurance Co. Lowers Stake in Monsanto Company (MON)
Nippon Life Insurance Co. decreased its stake in Monsanto Company (NYSE:MON) by 1.1% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 21,326 shares of the company’s stock after selling 243 shares during the period. Nippon Life Insurance Co.’s holdings in Monsanto Company were worth $2,180,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the company. Rehmann Capital Advisory Group boosted its stake in shares of Monsanto Company by 13.4% in the second quarter. Rehmann Capital Advisory Group now owns 8,087 shares of the company’s stock valued at $836,000 after buying an additional 953 shares in the last quarter. Callahan Advisors LLC boosted its stake in shares of Monsanto Company by 2.6% in the second quarter. Callahan Advisors LLC now owns 8,547 shares of the company’s stock valued at $884,000 after buying an additional 217 shares in the last quarter. Destination Wealth Management boosted its stake in shares of Monsanto Company by 42.1% in the second quarter. Destination Wealth Management now owns 72,219 shares of the company’s stock valued at $7,468,000 after buying an additional 21,380 shares in the last quarter. Albion Financial Group UT acquired a new stake in shares of Monsanto Company during the second quarter valued at about $210,000. Finally, Financial Architects Inc boosted its stake in shares of Monsanto Company by 145.4% in the second quarter. Financial Architects Inc now owns 2,905 shares of the company’s stock valued at $300,000 after buying an additional 1,721 shares in the last quarter. 73.70% of the stock is currently owned by institutional investors and hedge funds.
Monsanto Company (NYSE:MON) traded up 0.47% during mid-day trading on Friday, reaching $107.83. The company’s stock had a trading volume of 1,103,573 shares. The firm has a market capitalization of $47.29 billion, a price-to-earnings ratio of 29.57 and a beta of 1.01. The firm has a 50-day moving average of $105.18 and a 200 day moving average of $103.87. Monsanto Company has a 1-year low of $83.73 and a 1-year high of $114.26.
Monsanto Company (NYSE:MON) last announced its earnings results on Thursday, January 5th. The company reported $0.21 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.01 by $0.20. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The business earned $2.22 billion during the quarter. During the same period in the prior year, the business earned ($0.11) EPS. The company’s quarterly revenue was up 19.4% compared to the same quarter last year. Equities analysts expect that Monsanto Company will post $4.73 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, January 27th. Stockholders of record on Friday, January 6th will be issued a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 2.01%. The ex-dividend date of this dividend is Wednesday, January 4th. Monsanto Company’s dividend payout ratio is 58.86%.
COPYRIGHT VIOLATION WARNING: “Nippon Life Insurance Co. Lowers Stake in Monsanto Company (MON)” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at http://www.watchlistnews.com/nippon-life-insurance-co-lowers-stake-in-monsanto-company-mon/1060474.html.
MON has been the topic of several analyst reports. Zacks Investment Research raised shares of Monsanto Company from a “hold” rating to a “buy” rating and set a $122.00 target price on the stock in a report on Tuesday. Piper Jaffray Companies set a $128.00 target price on shares of Monsanto Company and gave the company a “buy” rating in a report on Thursday, September 15th. Sanford C. Bernstein reaffirmed a “sell” rating on shares of Monsanto Company in a report on Thursday, September 15th. BMO Capital Markets set a $128.00 target price on shares of Monsanto Company and gave the company a “buy” rating in a report on Thursday, September 15th. Finally, S&P Equity Research reaffirmed a “positive” rating on shares of Monsanto Company in a report on Thursday, September 15th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and seventeen have issued a buy rating to the company. Monsanto Company currently has an average rating of “Buy” and an average target price of $114.46.
In other news, EVP Steven Mizell sold 2,525 shares of the company’s stock in a transaction on Tuesday, January 10th. The stock was sold at an average price of $108.56, for a total transaction of $274,114.00. Following the completion of the sale, the executive vice president now directly owns 43,711 shares of the company’s stock, valued at $4,745,266.16. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Kerry J. Preete sold 2,745 shares of the company’s stock in a transaction on Thursday, November 17th. The shares were sold at an average price of $100.96, for a total value of $277,135.20. Following the sale, the executive vice president now directly owns 50,056 shares of the company’s stock, valued at $5,053,653.76. The disclosure for this sale can be found here. Insiders own 0.79% of the company’s stock.
Monsanto Company Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.